Clinical Trials
24 trialsNCT00898365 2026-05-18
Study of Kidney Tumors in Younger Patients
Children's Oncology Group
Completed
NCT02452554 2022-01-13
Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma
Children's Oncology Group
Phase 2 Completed
NCT00002611 2021-02-25
Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
Children's Oncology Group
Phase 3 Completed
NCT01305200 2019-09-17
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Children's Oncology Group
Phase 3 Completed
NCT00309907 2017-09-29
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Children's Oncology Group
Phase 2 Completed
NCT00335556 2017-07-21
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
Children's Oncology Group
Phase 2 Completed
NCT00674193 2017-05-17
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
Children's Oncology Group
Completed
NCT01808079 2016-08-22
Gene Analysis in Studying Susceptibility to Wilms Tumor
Children's Oncology Group
Completed
NCT01576198 2016-07-14
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT01550393 2016-07-11
Biomarkers in Urine Samples From Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT00088803 2016-05-19
DNA Variations in the Gene in Young Patients With Wilms' Tumor
Children's Oncology Group
Completed
NCT00897637 2016-05-19
Gene Expression Profiles to Categorize Wilms Tumors
Children's Oncology Group
Completed
NCT01118078 2016-05-19
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
Children's Oncology Group
Completed
NCT01493817 2016-05-19
Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT01314391 2016-05-18
Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT01542333 2016-05-18
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT01576211 2016-05-18
Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT00080873 2016-01-07
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
Children's Oncology Group
Phase NA Completed
NCT01004783 2015-05-07
Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Children's Oncology Group
Completed
NCT01614808 2015-05-07
Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Completed
NCT00002610 2014-07-25
Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
Children's Oncology Group
Phase 3 Completed
NCT00003597 2014-07-24
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT01048892 2014-01-30
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Children's Oncology Group
Phase 1 Completed
NCT00003938 2012-09-24
Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed